1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Marx, U.C. Roesch, P. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US J.Biol.Chem. JBCHA3 0071 0021-9258 270 15194 15202 10.1074/jbc.270.25.15194 7797503 Structure of human parathyroid hormone 1-37 in solution. 1995 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 4409.144 HUMAN PARATHYROID HORMONE FRAGMENT 1 - 37 1 man polymer no no SVSEIQLMHNLGKHLNSMERVEWLRKKLQDVHNFVAL SVSEIQLMHNLGKHLNSMERVEWLRKKLQDVHNFVAL A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo sample 9606 Homo sapiens repository Initial release Version format compliance Version format compliance Database references 1 0 1995-07-10 1 1 2008-03-24 1 2 2011-07-13 1 3 2012-02-22 Y 1995-02-14 REL 10 BRUNGER refinement X-PLOR SER 1 n 1 SER 1 A VAL 2 n 2 VAL 2 A SER 3 n 3 SER 3 A GLU 4 n 4 GLU 4 A ILE 5 n 5 ILE 5 A GLN 6 n 6 GLN 6 A LEU 7 n 7 LEU 7 A MET 8 n 8 MET 8 A HIS 9 n 9 HIS 9 A ASN 10 n 10 ASN 10 A LEU 11 n 11 LEU 11 A GLY 12 n 12 GLY 12 A LYS 13 n 13 LYS 13 A HIS 14 n 14 HIS 14 A LEU 15 n 15 LEU 15 A ASN 16 n 16 ASN 16 A SER 17 n 17 SER 17 A MET 18 n 18 MET 18 A GLU 19 n 19 GLU 19 A ARG 20 n 20 ARG 20 A VAL 21 n 21 VAL 21 A GLU 22 n 22 GLU 22 A TRP 23 n 23 TRP 23 A LEU 24 n 24 LEU 24 A ARG 25 n 25 ARG 25 A LYS 26 n 26 LYS 26 A LYS 27 n 27 LYS 27 A LEU 28 n 28 LEU 28 A GLN 29 n 29 GLN 29 A ASP 30 n 30 ASP 30 A VAL 31 n 31 VAL 31 A HIS 32 n 32 HIS 32 A ASN 33 n 33 ASN 33 A PHE 34 n 34 PHE 34 A VAL 35 n 35 VAL 35 A ALA 36 n 36 ALA 36 A LEU 37 n 37 LEU 37 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 4 A A O H TRP LYS 23 27 1.60 1 A ARG 20 0.264 SIDE CHAIN 1 A ARG 25 0.317 SIDE CHAIN 2 A ARG 20 0.315 SIDE CHAIN 2 A ARG 25 0.313 SIDE CHAIN 3 A ARG 20 0.297 SIDE CHAIN 3 A ARG 25 0.309 SIDE CHAIN 4 A ARG 20 0.315 SIDE CHAIN 4 A ARG 25 0.312 SIDE CHAIN 5 A ARG 20 0.307 SIDE CHAIN 5 A ARG 25 0.312 SIDE CHAIN 6 A ARG 20 0.316 SIDE CHAIN 6 A ARG 25 0.314 SIDE CHAIN 7 A ARG 20 0.294 SIDE CHAIN 7 A ARG 25 0.317 SIDE CHAIN 8 A ARG 20 0.301 SIDE CHAIN 8 A ARG 25 0.312 SIDE CHAIN 9 A ARG 20 0.300 SIDE CHAIN 9 A ARG 25 0.313 SIDE CHAIN 10 A ARG 20 0.315 SIDE CHAIN 10 A ARG 25 0.311 SIDE CHAIN 1 A GLU 4 -97.91 37.51 1 A GLN 6 -67.45 74.08 1 A LEU 7 74.30 45.31 1 A ASN 10 23.76 62.49 1 A ASN 16 -101.34 -162.30 1 A GLN 29 -98.46 49.78 1 A ASP 30 -155.94 -43.61 1 A ASN 33 -164.21 -49.30 2 A VAL 2 71.14 139.39 2 A GLU 4 -102.46 44.05 2 A ILE 5 -153.68 68.67 2 A MET 18 84.27 -51.98 2 A ASP 30 -142.19 19.66 2 A VAL 31 -137.77 -57.07 2 A PHE 34 -69.08 98.75 3 A VAL 2 67.25 160.09 3 A SER 3 -171.01 115.59 3 A GLU 4 -157.15 37.83 3 A LEU 11 67.34 -165.01 3 A LYS 13 59.79 17.99 3 A HIS 14 164.15 125.85 3 A MET 18 86.25 -51.12 3 A ALA 36 -104.38 45.21 4 A VAL 2 51.11 -173.67 4 A GLU 4 -107.62 53.27 4 A ASN 10 -98.92 52.92 4 A MET 18 84.20 -38.48 5 A LEU 11 85.46 15.60 5 A LYS 13 57.46 83.02 5 A PHE 34 58.77 70.03 6 A SER 3 59.14 83.33 6 A LEU 11 -125.93 -144.81 6 A HIS 14 -163.97 90.42 6 A ASN 33 59.64 88.36 6 A ALA 36 -102.97 -140.86 7 A SER 3 -150.22 31.86 7 A HIS 14 68.99 116.00 7 A ASN 16 -134.59 -83.90 7 A SER 17 -147.46 -67.78 7 A LYS 26 -98.00 -89.41 7 A LEU 28 60.11 60.75 7 A PHE 34 68.90 102.45 7 A ALA 36 -132.65 -150.34 8 A GLN 29 -115.01 53.91 8 A ASP 30 -151.15 -61.01 8 A HIS 32 72.89 -68.63 8 A ALA 36 -158.10 -149.32 9 A SER 3 63.48 91.14 9 A ILE 5 -147.53 26.77 9 A LYS 13 70.40 116.22 10 A VAL 2 71.05 133.32 10 A GLU 4 -150.42 36.98 10 A LEU 15 51.65 -161.35 10 A ASN 16 -146.68 -76.07 10 A SER 17 -134.46 -86.24 10 A GLN 29 -96.74 30.21 10 A ASP 30 -144.33 19.07 10 A ALA 36 -145.27 -150.12 model building X-PLOR 3.1 refinement X-PLOR 3.1 phasing X-PLOR 3.1 HUMAN PARATHYROID HORMONE FRAGMENT 1 - 37 (HPTH(1-37)) (NMR, 10 STRUCTURES) STRUCTURE OF HUMAN PARATHYROID HORMONE 1-37 IN SOLUTION 1 Y N A GLN 6 A GLN 6 HELX_P A HIS 9 A HIS 9 1 H1 4 A SER 17 A SER 17 HELX_P A LEU 28 A LEU 28 1 H2 12 HORMONE HORMONE PTHY_HUMAN UNP 1 1 P01270 MIPAKDMAKVMIVMLAICFLTKSDGKSVKKRSVSEIQLMHNLGKHLNSMERVEWLRKKLQDVHNFVALGAPLAPRDAGSQ RPRKKEDNVLVESHEKSLGEADKADVNVLTKAKSQ 32 68 1HPH 1 37 P01270 A 1 1 37 1 P 1